Cervistab is an electro-pneumatic device that produces flexion push-loading events in an ecological rugby position (i.e. similar to on-pitch position) to assess neck extensors muscle response to a flexion perturbation. This response is important for preventing head/neck injuries in Rugby, however there is a clear lack of validated devices in the literature. This study tested the reliability of this new device designed to investigate the extensor neck muscle response to flexion head push-loading event. Twelve healthy volunteers were tested with Cervistab in a test/retest protocol. Participants experienced push-loading events with preloading on extensors muscles at 50% and 20% of their maximum voluntary isometric extension strength. Muscle mechanical latency, non-reflex and reflex rates of force development were measured twice, 7days apart. Reliability was assessed by intraclass correlation coefficient (ICC), coefficient of variation (CV), and the Bland and Altman graphical approach. For both preloading conditions, muscle mechanical latency showed good ICC values from 0.81 to 0.88 and good CV (3.5%). Non-reflex and reflex rates of force development showed good reliability with ICC ranging from 0.78 to 0.89, and moderate CV values ranging from 8.5% to 14.5%, depending on the preloading condition (20% and 50% of maximal isometric extension contraction respectively). Bland and Altman plots showed no significant fixed or proportional bias. Overall, the reliability of measurements obtained with Cervistab is good. Cervistab can be used in practice to improve our understanding of the neuromechanical factors that influence neck stability, to help prevent head/neck injuries and to guide the decision to return to play after a head or neck injury.
Read full abstract